Department of Chemistry
PhD, Organic Chemistry, State University of New York at Buffalo MS, Chemistry, Institute of Organic Chemistry, Sofia, Bulgaria MS, Pharmacy, State University Medical Academy, Sofia, Bulgaria
Dr. Konaklieva’s research is in the area of exploring different approaches for delaying of microbial resistance. Current projects include computer-aided design and synthesis of novel beta-lactams as well as development of synthetic methodology for preparation of other “non-conventional” candidates as beta-lactamase and Human Leukocyte Elastase inhibitors.
The Research Corporation, Beta-Lactamase activated NO-containing beta-lactams (2002)
Monika I. Konaklieva and Balbina J. Plotkin, “Bioisosters of Beta-Lactams as Anti-Infectives" Current Medicinal Chemistry Anti-Infective Agents, 2,4 (2003)
Timothy E. Long; Edward Turos; Monika I. Konaklieva; Allison L. Blum; Amal Amry;Ejae A. Baker; Lita S. Suwandi; Melodie D. McCain; Miti F. Rahman; Sonja Dickey;Daniel V. Lim, “Effect of Aryl Ring Fluorination on the Antibacterial Properties of C4
Aryl- Substituted N-Methylthio beta- Lactams” Bioorganic & Medicinal Chemistry, 11,1859, (2003)
Jeffrey R. Deschamps., Lita Suwandi, and Monika Konaklieva, “3,3-Bis(methylthio)-2-oxo-N-phenylpropanamide”Acta Crystallographica Section E, Structure Reports, E59, 1,(2003)